HIV 1 News and Research

RSS

Global Fund board members discuss new funding allocation model amid some concerns from TB advocates

The board of the Global Fund to Fight AIDS, Tuberculosis and Malaria began a two-day meeting in Geneva on Thursday, "with one topic high on the agenda: a new funding model," Devex's "Development Newswire" reports.

15 Sep 2012

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP.

15 Sep 2012

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.

14 Sep 2012

Uganda releases strategy to reduce HIV infections; Activists question country's ability to meet goals

"In response to rising HIV prevalence, Uganda's government has announced a strategy to reduce new HIV infections by up to 30 percent by 2015, but activists have cast doubt on its ability to achieve this ambitious goal," PlusNews reports.

14 Sep 2012

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

14 Sep 2012

Children's Hospital Oakland to celebrate 100th birthday

Children's Hospital & Research Center Oakland is celebrating its 100th birthday. The free-standing, not-for-profit pediatric medical center was founded in 1912 and opened for business in 1914. Children's Hospital Oakland will celebrate the landmark birthday for two years and kicked off festivities with a birthday party at Children's Fairyland in Oakland on September 8.

12 Sep 2012

VOA news examines AIDS among marginalized groups in Burma

VOA News examines AIDS among high-risk groups in Burma, also known as Myanmar. "Burma's AIDS epidemic mostly affects marginalized groups, such as the gay community," the news service writes, adding, "About one percent of Burma's population is HIV-positive," but "among high-risk groups, such as men who have sex with men, health workers estimate as many as 11 percent have HIV."

12 Sep 2012

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."

12 Sep 2012

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

The Economist reports on a demonstration by about 300 people living with HIV and activists outside the headquarters of China's Henan provincial government in Zhengzhou on August 27.

12 Sep 2012

Novel method could help advance fight against persistent 'HIV latency'

Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection-by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

12 Sep 2012

Religious groups play positive and critical roles in fighting AIDS epidemic

While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive -- and critical -- roles in fighting the epidemic, according to sociologists.

12 Sep 2012

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

The Center for Strategic and International Studies (CSIS) on Thursday hosted a panel discussion focusing on the policy implications of findings published by the Lancet in a special series on HIV/AIDS and men who have sex with men (MSM), the Center for Global Health Policy's "Science Speaks" blog reports.

11 Sep 2012

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

11 Sep 2012

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.

10 Sep 2012

Study measures cost-effectiveness of on-site rapid HIV testing in drug abuse treatment programs

Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs.

10 Sep 2012

New strategy will have positive impact on people with brain disorders

New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.

10 Sep 2012

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers of AIDS Vaccine 2012 say," the Center for Global Health Policy's "Science Speaks" blog reports.

7 Sep 2012

NPR blog examines 'test and treat' approach as HIV/AIDS prevention tactic

NPR's "Shots" blog examines the "test and treat" approach to HIV care and prevention, which "relies on the fact that taking HIV drugs dramatically reduces a person's risk of transmitting the virus to others," and, "[a]s more and more people are put on medication, the epidemic theoretically should fizzle out." The blog continues, "Test and treat sounds good on paper, but some doctors and policymakers have doubts about its feasibility on a large scale."

7 Sep 2012

Pesticide-related illnesses to cost up to $90B between 2005-2020 in sub-Saharan Africa, UNEP report says

"The potential cost of pesticide-related illnesses in sub-Saharan African between 2005 and 2020 could reach $90 billion, according to a U.N. report released on Wednesday highlighting the growing health and environmental hazards from chemicals," the Associated Press/Guardian reports.

7 Sep 2012

Reuters examines challenges to implementing 'treatment as prevention,' other HIV prevention strategies in current economic climate

In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."

7 Sep 2012

HIV 1 News and Research

Global Fund board members discuss new funding allocation model amid some concerns from TB advocates

Study estimates drug concentrations of Truvada and tenofovir to reduce risk of HIV among MSM

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

Uganda releases strategy to reduce HIV infections; Activists question country's ability to meet goals

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

Children's Hospital Oakland to celebrate 100th birthday

VOA news examines AIDS among marginalized groups in Burma

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

Novel method could help advance fight against persistent 'HIV latency'

Religious groups play positive and critical roles in fighting AIDS epidemic

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Study measures cost-effectiveness of on-site rapid HIV testing in drug abuse treatment programs

New strategy will have positive impact on people with brain disorders

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

NPR blog examines 'test and treat' approach as HIV/AIDS prevention tactic

Pesticide-related illnesses to cost up to $90B between 2005-2020 in sub-Saharan Africa, UNEP report says

Reuters examines challenges to implementing 'treatment as prevention,' other HIV prevention strategies in current economic climate

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News